- Home
- NERV vs VSEE Comparison
NERV vs VSEE Comparison
Compare NERV & VSEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- VSEE
- Stock Information
- Founded
- NERV 2007
- VSEE 2008
- Country
- NERV United States
- VSEE United States
- Employees
- NERV N/A
- VSEE N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- VSEE
- Sector
- NERV Health Care
- VSEE
- Exchange
- NERV Nasdaq
- VSEE NYSE
- Market Cap
- NERV 18.3M
- VSEE 20.1M
- IPO Year
- NERV 2014
- VSEE N/A
- Fundamental
- Price
- NERV $2.20
- VSEE $1.35
- Analyst Decision
- NERV Hold
- VSEE
- Analyst Count
- NERV 1
- VSEE 0
- Target Price
- NERV $5.00
- VSEE N/A
- AVG Volume (30 Days)
- NERV 25.3K
- VSEE 935.9K
- Earning Date
- NERV 11-05-2024
- VSEE 11-26-2024
- Dividend Yield
- NERV N/A
- VSEE N/A
- EPS Growth
- NERV N/A
- VSEE N/A
- EPS
- NERV N/A
- VSEE N/A
- Revenue
- NERV N/A
- VSEE $8,064,925.00
- Revenue This Year
- NERV N/A
- VSEE N/A
- Revenue Next Year
- NERV N/A
- VSEE N/A
- P/E Ratio
- NERV N/A
- VSEE N/A
- Revenue Growth
- NERV N/A
- VSEE N/A
- 52 Week Low
- NERV $2.10
- VSEE $1.12
- 52 Week High
- NERV $13.49
- VSEE $33.08
- Technical
- Relative Strength Index (RSI)
- NERV 34.31
- VSEE N/A
- Support Level
- NERV $2.26
- VSEE N/A
- Resistance Level
- NERV $2.43
- VSEE N/A
- Average True Range (ATR)
- NERV 0.16
- VSEE 0.00
- MACD
- NERV -0.01
- VSEE 0.00
- Stochastic Oscillator
- NERV 13.71
- VSEE 0.00
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About VSEE VSEE HEALTH INC
VSee Health Inc is a telehealth software platform. VSee's telemedicine solution, offering a fast, secure text + video collaboration app HIPAA messenger, and fully customizable virtual waiting rooms and clinics, is a complete telehealth platform that fits into any workflow. The VSee proprietary technology platform and modular software solution enable users to plug and play telehealth services with end-to-end encrypted video streaming integrated with patient metrics, electronic medical records, and other sensitive data, with multiple other interactive functionalities. The company's products include VSee Clinic, VSee Messenger, VSee APIs, VSee Remote patient monitoring, VSee Telehealth Staffing.